Clinical trial

Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation…

NCT00003610 · Alliance for Clinical Trials in Oncology, Other · Completed

Key facts

NCT number NCT00003610
Title Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Official title Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Head and Neck Cancer, Radiation Toxicity
Intervention type Dietary Supplement, Other, Radiation
Interventions capsaicin, placebo, radiation therapy
Enrollment 18
Start date Oct 1, 1998
Primary completion Jul 1, 2006
Completion Jul 1, 2006
First posted Jul 22, 2004
Last update posted Jul 13, 2016
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies